Buspirone Hydrochloride Tablet
Product Images NDC 16729-201

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 16729-201). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Accord Healthcare Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 10mg 500)

BusPIRone Hydrochloride Tablets USP 10 mg oral tablets label by Accord Healthcare Inc. The label states the product contains 500 tablets, includes storage instructions at 25°C with permitted excursions, and advises keeping medicine out of children's reach. It notes the product is prescription only and directs pharmacists to dispense with patient information leaflet. Manufacturer details include Accord Healthcare Inc., Durham, NC, and Intas Pharmaceuticals Limited, India.*

FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 15mg 500)

BusPIRone Hydrochloride Tablets USP 15 mg oral tablets label for prescription use. The label states the dosage strength of 15 mg, quantity of 500 tablets, and instructions to store between 15°C to 30°C, with warnings to keep out of reach of children. It is manufactured for Accord Healthcare Inc., Durham, NC, and by Intas Pharmaceuticals Limited, India. The label includes NDC 16729-203, barcodes, and a note to dispense with patient information leaflet.*

FDA Label Image

Buspirone 30mg 60

Label for Buspirone Hydrochloride Tablets USP 30 mg, oral tablet by Accord Healthcare Inc. The label shows the dosage strength, quantity of 60 tablets, storage instructions, and dispensing information. It contains the NDC 16729-289-12 and manufacturer details including Accord Healthcare and Intas Pharmaceuticals Limited.*

FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 5mg 500)

Buspirone Hydrochloride 5 mg oral tablets label showing the product name, strength, and form. The label indicates a pack size of 500 tablets, manufacturer Accord Healthcare Inc. Printed storage instructions, dispensing information, and barcode are also visible. The label is mainly white with purple and magenta highlights.*

FDA Label Image

Buspirone Hydrochloride Tablets (Buspirone 7pt5mg 500)

Label for BusPIRone Hydrochloride Tablets USP 7.5 mg by Accord Healthcare Inc. The label includes dosage strength, prescription-only status, storage instructions, warning to keep out of reach of children, and manufacturing information. Packaging indicates 500 tablets with multiple barcodes and a designated area for lot and expiration data.*

FDA Label Image

Dosage Table (Buspirone Fig 1)

An instructional diagram showing how to split Buspirone Hydrochloride tablets to achieve specific doses when prescribed 15 mg or 30 mg tablets. It displays the tablet scored and the resulting doses for whole tablets, halves, and thirds to guide correct dosing.*

FDA Label Image

Quadrisect Photo (Buspirone Fig 2)

An instructional illustration showing how to identify and handle Buspirone Hydrochloride tablets of 15 mg and 30 mg strengths. The left panel depicts a 15 mg tablet marked 'B M 4' being held between two fingers. The right panel shows a 30 mg tablet marked 'B 8' also held by two fingers. Labels under each panel indicate the respective tablet strengths.*

FDA Label Image

Buspirone Structural Formula (Buspirone Str)

Chemical structure of buspirone hydrochloride depicted as a molecular diagram with atoms and bonds, showing key functional groups and the HCl component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.